SOMMEIJER, Dirkje W. et al. The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17. Acta Oncologica, [S. l.], v. 53, n. 7, p. 877–884, 2014. DOI: 10.3109/0284186X.2013.879202. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/27099. Acesso em: 27 nov. 2024.